Previous 10 | Next 10 |
Gainers: AVEO Pharmaceuticals (NASDAQ: AVEO ) +35% . ADMA Biologics (NASDAQ: ADMA ) +32% . Sangamo Therapeutics (NASDAQ: SGMO ) +27% . Castor Maritime (NASDAQ: CTRM ) +24% . EDAP TMS S.A. (NASDAQ: EDAP ) +23% . Riot Blockchain (NASDAQ: RIOT ) +22% . Vaccinex (NASDAQ: VCNX ) +1...
NovaBay Pharmaceuticals (NYSEMKT: NBY ) invests $5M to support commercialization of Avenova sales in U.S. while maintaining cost effectiveness. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Reiterates long-term commitment to eye care specialists and patients Capital investment supports cost-efficient growth strategy NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the...
NovaBay Pharmaceuticals, Inc (NBY) Q4 2018 Results Earnings Conference Call March 28, 2019 04:30 PM ET Company Participants Bruce Voss - IR, LHA Justin Hall - Interim President and CEO Jason Raleigh - Interim CFO Conference Call Participants Yi Chen - H.C. Wainwright ...
NovaBay (NYSEMKT: NBY ): Q4 GAAP EPS of -$0.07 misses by $0.01 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Conference call begins today at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova ® for the domestic eye care market, reports financial results for the three and...
Citing a " strategic shift " in its commercialization approach, NovaBay Pharmaceuticals (NYSEMKT: NBY ) will now sharpen its focus on selling Avenova in areas that have the most volume potential. More news on: NovaBay Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
Makes board and executive changes and reduces U.S. sales organization to focus only on high-performing, high potential sales territories and specialty pharmacy channel expansion Company to hold 2018 fourth quarter and full year conference call on March 28, 2019 NovaBay ® Pha...
Gainers: TMSR Holding Company (NASDAQ: TMSR ) +223%. Integrated Media Technology (NASDAQ: IMTE ) +104% . Titan Pharmaceuticals (NASDAQ: TTNP ) +34%. Professional Diversity Network (NASDAQ: IPDN ) +30% . Continental Materials (NYSEMKT: CUO ) +29% . Gravity (NASDAQ: GRVY ) ...
This article serves as a portfolio-based market barometer that shows which types of portfolio algorithms are outperforming from week to week. Leveraging different forensic, value, fundamental, momentum, and anomaly portfolios, we may be able to anticipate changes not only in market direction b...
News, Short Squeeze, Breakout and More Instantly...
NovaBay Pharmaceuticals Inc. Company Name:
NBY Stock Symbol:
NYSE Market:
NovaBay Pharmaceuticals Inc. Website:
NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2024 after market close on Tuesday, August 13, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Ea...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reports record sales of Avenova ® -branded eyecare products during the Amazon Prime Day event, which was held July 16-17, 2024. Over the two-day period, Avenova sales were 17% higher compared with Prime Day 2023 and were up 40% over ...
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants, Series F-1 warrants, Series F-2 warrants and Series F-3 warrants f...